Hep Dynamics LLC announces the launch of a new podcast series. “Surfing the NASH Tsunami”, focused on challenges, solutions and news in NASH drug development.
Fatty Liver Researcher and endocrinology key opinion leader Ken Cusi discusses the high levels of NAFLD prevalence and fibrosis among
